In today’s fast-paced world, respiratory health has become a pressing concern for many. With increasing pollution, sedentary ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung ...

Researchers have found in a phase 3 trials that Dupilumab significantly reduced moderate or severe COPD exacerbations ...

As the Pope battles bronchitis, it‘s a reminder of how a standard winter cough can develop – and what you can do to help ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...